Department of Geriatric Cardiology, Chinese PLA General Hospital, Beijing, People's Republic of China.
Clin Interv Aging. 2013;8:409-17. doi: 10.2147/CIA.S42700. Epub 2013 Apr 15.
To analyze the relationship between N-terminal pro-brain natriuretic peptide (NT-proBNP) and renal function, and compare the ability and cut-off thresholds of NT-proBNP to detect chronic heart failure (CHF) and predict mortality in elderly Chinese coronary artery disease (CAD) patients with and without chronic kidney disease (CKD).
The study included 999 CAD patients older than 60 years. The endpoint was all-cause mortality over a mean follow-up period of 417 days.
The median age was 86 years (range: 60-104 years), and the median NT-proBNP level was 409.8 pg/mL. CKD was present in 358 patients. Three hundred and six patients were positive for CHF. One hundred and ten CKD patients and 105 non-CKD patients died. Not only CKD, but also estimated glomerular filtration rate independently affected NT-proBNP. NT-proBNP detected CHF with a cut-off value of 298.4 pg/mL in non-CKD patients and a cut-off value of 435.7 pg/mL in CKD patients. NT-proBNP predicted death with a cut-off value of 369.5 pg/mL in non-CKD patients and a cut-off value of 2584.1 pg/mL in CKD patients. The NT-proBNP level was significantly related to the prevalence of CHF and all-cause mortality in CAD patients with and without CKD; this effect persisted after adjustment. The crude and multiple adjusted hazard ratios of NT-proBNP to detect CHF and predict mortality were significantly higher in patients with CKD compared with the remainder of the population. The addition of NT-proBNP to the three-variable and six-variable models generated a significant increase in the C-statistic.
Amongst elderly Chinese CAD patients, there was an independently inverse association between NT-proBNP and renal function. With the higher cutoff points, NT-proBNP better detected CHF and better predicted mortality in CKD patients than in non-CKD patients.
分析 N 端脑利钠肽前体(NT-proBNP)与肾功能的关系,并比较 NT-proBNP 检测老年冠心病(CAD)合并和不合并慢性肾脏病(CKD)患者慢性心力衰竭(CHF)的能力和截断值,以及预测死亡率。
该研究纳入了 999 名年龄大于 60 岁的 CAD 患者。终点为平均随访 417 天后的全因死亡率。
中位年龄为 86 岁(范围:60-104 岁),中位 NT-proBNP 水平为 409.8 pg/ml。358 例患者合并 CKD。306 例患者 CHF 阳性。110 例 CKD 患者和 105 例非 CKD 患者死亡。不仅 CKD,而且估计肾小球滤过率也独立影响 NT-proBNP。在非 CKD 患者中,NT-proBNP 检测 CHF 的截断值为 298.4 pg/ml,在 CKD 患者中为 435.7 pg/ml。在非 CKD 患者中,NT-proBNP 预测死亡的截断值为 369.5 pg/ml,在 CKD 患者中为 2584.1 pg/ml。NT-proBNP 水平与 CAD 合并和不合并 CKD 患者 CHF 的患病率和全因死亡率显著相关;这种影响在调整后仍然存在。与其余人群相比,CKD 患者 NT-proBNP 检测 CHF 和预测死亡率的粗值和多变量调整后比值比均显著更高。将 NT-proBNP 加入三变量和六变量模型后,C 统计量显著增加。
在老年中国 CAD 患者中,NT-proBNP 与肾功能呈独立负相关。与非 CKD 患者相比,较高的截断值时,NT-proBNP 更好地检测出 CKD 患者的 CHF,更好地预测 CKD 患者的死亡率。